世界の動物用バイオ医薬品市場インサイト及び予測(ワクチン(細菌)、免疫血清、抗原&抗体、その他)

◆英語タイトル:Global Animal Biopharma Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22DE18836)◆商品コード:QY22DE18836
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年12月
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、動物用バイオ医薬品の世界市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
動物用バイオ医薬品のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
動物用バイオ医薬品の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
動物用バイオ医薬品のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面に関しては、当レポートは2017年から2022年までの動物用バイオ医薬品の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面に関しては、当レポートは2017年から2022年までの地域別、企業別、種類別、用途別の動物用バイオ医薬品の売上および2028年までの予測に焦点を当てています。

動物用バイオ医薬品のグローバル主要企業には、Boehringer Ingelheim、Invetx、CZ Vaccines、Scout Bio、Zoetis、Merck、Elanco、Virbac、Ceva、Vetoquinolなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

動物用バイオ医薬品市場は、種類と用途によって区分されます。世界の動物用バイオ医薬品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ワクチン(細菌)、免疫血清、抗原&抗体、その他

【用途別セグメント】
予防、治療

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 動物用バイオ医薬品製品概要
- 種類別市場(ワクチン(細菌)、免疫血清、抗原&抗体、その他)
- 用途別市場(予防、治療)
- 調査の目的
・エグゼクティブサマリー
- 世界の動物用バイオ医薬品販売量予測2017-2028
- 世界の動物用バイオ医薬品売上予測2017-2028
- 動物用バイオ医薬品の地域別販売量
- 動物用バイオ医薬品の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別動物用バイオ医薬品販売量
- 主要メーカー別動物用バイオ医薬品売上
- 主要メーカー別動物用バイオ医薬品価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(ワクチン(細菌)、免疫血清、抗原&抗体、その他)
- 動物用バイオ医薬品の種類別販売量
- 動物用バイオ医薬品の種類別売上
- 動物用バイオ医薬品の種類別価格
・用途別市場規模(予防、治療)
- 動物用バイオ医薬品の用途別販売量
- 動物用バイオ医薬品の用途別売上
- 動物用バイオ医薬品の用途別価格
・北米市場
- 北米の動物用バイオ医薬品市場規模(種類別、用途別)
- 主要国別の動物用バイオ医薬品市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの動物用バイオ医薬品市場規模(種類別、用途別)
- 主要国別の動物用バイオ医薬品市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の動物用バイオ医薬品市場規模(種類別、用途別)
- 主要国別の動物用バイオ医薬品市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の動物用バイオ医薬品市場規模(種類別、用途別)
- 主要国別の動物用バイオ医薬品市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの動物用バイオ医薬品市場規模(種類別、用途別)
- 主要国別の動物用バイオ医薬品市場規模(トルコ、サウジアラビア)
・企業情報
Boehringer Ingelheim、Invetx、CZ Vaccines、Scout Bio、Zoetis、Merck、Elanco、Virbac、Ceva、Vetoquinol
・産業チェーン及び販売チャネル分析
- 動物用バイオ医薬品の産業チェーン分析
- 動物用バイオ医薬品の原材料
- 動物用バイオ医薬品の生産プロセス
- 動物用バイオ医薬品の販売及びマーケティング
- 動物用バイオ医薬品の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 動物用バイオ医薬品の産業動向
- 動物用バイオ医薬品のマーケットドライバー
- 動物用バイオ医薬品の課題
- 動物用バイオ医薬品の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Animal Biopharma estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Animal Biopharma is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Animal Biopharma is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Animal Biopharma is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Animal Biopharma include Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac and Ceva, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Animal Biopharma companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Animal Biopharma market. Further, it explains the major drivers and regional dynamics of the global Animal Biopharma market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Boehringer Ingelheim
Invetx
CZ Vaccines
Scout Bio
Zoetis
Merck
Elanco
Virbac
Ceva
Vetoquinol
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Animal Biopharma Segment by Type
Vaccine (Bacteria)
Immune Serum
Antigen & Antibody
Others
Animal Biopharma Segment by Application
Prevention
Treatment
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Animal Biopharma market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Animal Biopharma market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Animal Biopharma, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Animal Biopharma, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Biopharma revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Animal Biopharma market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Animal Biopharma revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac and Ceva, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Animal Biopharma in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Biopharma companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Biopharma revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Biopharma Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vaccine (Bacteria)
1.2.3 Immune Serum
1.2.4 Antigen & Antibody
1.2.5 Others
1.3 Market by Application
1.3.1 Global Animal Biopharma Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Animal Biopharma Market Perspective (2017-2028)
2.2 Animal Biopharma Growth Trends by Region
2.2.1 Animal Biopharma Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Animal Biopharma Historic Market Size by Region (2017-2022)
2.2.3 Animal Biopharma Forecasted Market Size by Region (2023-2028)
2.3 Animal Biopharma Market Dynamics
2.3.1 Animal Biopharma Industry Trends
2.3.2 Animal Biopharma Market Drivers
2.3.3 Animal Biopharma Market Challenges
2.3.4 Animal Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Biopharma Players by Revenue
3.1.1 Global Top Animal Biopharma Players by Revenue (2017-2022)
3.1.2 Global Animal Biopharma Revenue Market Share by Players (2017-2022)
3.2 Global Animal Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Biopharma Revenue
3.4 Global Animal Biopharma Market Concentration Ratio
3.4.1 Global Animal Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Biopharma Revenue in 2021
3.5 Animal Biopharma Key Players Head office and Area Served
3.6 Key Players Animal Biopharma Product Solution and Service
3.7 Date of Enter into Animal Biopharma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Biopharma Breakdown Data by Type
4.1 Global Animal Biopharma Historic Market Size by Type (2017-2022)
4.2 Global Animal Biopharma Forecasted Market Size by Type (2023-2028)
5 Animal Biopharma Breakdown Data by Application
5.1 Global Animal Biopharma Historic Market Size by Application (2017-2022)
5.2 Global Animal Biopharma Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Animal Biopharma Market Size (2017-2028)
6.2 North America Animal Biopharma Market Size by Type
6.2.1 North America Animal Biopharma Market Size by Type (2017-2022)
6.2.2 North America Animal Biopharma Market Size by Type (2023-2028)
6.2.3 North America Animal Biopharma Market Share by Type (2017-2028)
6.3 North America Animal Biopharma Market Size by Application
6.3.1 North America Animal Biopharma Market Size by Application (2017-2022)
6.3.2 North America Animal Biopharma Market Size by Application (2023-2028)
6.3.3 North America Animal Biopharma Market Share by Application (2017-2028)
6.4 North America Animal Biopharma Market Size by Country
6.4.1 North America Animal Biopharma Market Size by Country (2017-2022)
6.4.2 North America Animal Biopharma Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Animal Biopharma Market Size (2017-2028)
7.2 Europe Animal Biopharma Market Size by Type
7.2.1 Europe Animal Biopharma Market Size by Type (2017-2022)
7.2.2 Europe Animal Biopharma Market Size by Type (2023-2028)
7.2.3 Europe Animal Biopharma Market Share by Type (2017-2028)
7.3 Europe Animal Biopharma Market Size by Application
7.3.1 Europe Animal Biopharma Market Size by Application (2017-2022)
7.3.2 Europe Animal Biopharma Market Size by Application (2023-2028)
7.3.3 Europe Animal Biopharma Market Share by Application (2017-2028)
7.4 Europe Animal Biopharma Market Size by Country
7.4.1 Europe Animal Biopharma Market Size by Country (2017-2022)
7.4.2 Europe Animal Biopharma Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Biopharma Market Size (2017-2028)
8.2 Asia-Pacific Animal Biopharma Market Size by Type
8.2.1 Asia-Pacific Animal Biopharma Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Animal Biopharma Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Animal Biopharma Market Share by Type (2017-2028)
8.3 Asia-Pacific Animal Biopharma Market Size by Application
8.3.1 Asia-Pacific Animal Biopharma Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Animal Biopharma Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Animal Biopharma Market Share by Application (2017-2028)
8.4 Asia-Pacific Animal Biopharma Market Size by Region
8.4.1 Asia-Pacific Animal Biopharma Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Animal Biopharma Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Animal Biopharma Market Size (2017-2028)
9.2 Latin America Animal Biopharma Market Size by Type
9.2.1 Latin America Animal Biopharma Market Size by Type (2017-2022)
9.2.2 Latin America Animal Biopharma Market Size by Type (2023-2028)
9.2.3 Latin America Animal Biopharma Market Share by Type (2017-2028)
9.3 Latin America Animal Biopharma Market Size by Application
9.3.1 Latin America Animal Biopharma Market Size by Application (2017-2022)
9.3.2 Latin America Animal Biopharma Market Size by Application (2023-2028)
9.3.3 Latin America Animal Biopharma Market Share by Application (2017-2028)
9.4 Latin America Animal Biopharma Market Size by Country
9.4.1 Latin America Animal Biopharma Market Size by Country (2017-2022)
9.4.2 Latin America Animal Biopharma Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Biopharma Market Size (2017-2028)
10.2 Middle East & Africa Animal Biopharma Market Size by Type
10.2.1 Middle East & Africa Animal Biopharma Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Animal Biopharma Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Animal Biopharma Market Share by Type (2017-2028)
10.3 Middle East & Africa Animal Biopharma Market Size by Application
10.3.1 Middle East & Africa Animal Biopharma Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Animal Biopharma Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Animal Biopharma Market Share by Application (2017-2028)
10.4 Middle East & Africa Animal Biopharma Market Size by Country
10.4.1 Middle East & Africa Animal Biopharma Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Animal Biopharma Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Animal Biopharma Introduction
11.1.4 Boehringer Ingelheim Revenue in Animal Biopharma Business (2017-2022)
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Invetx
11.2.1 Invetx Company Details
11.2.2 Invetx Business Overview
11.2.3 Invetx Animal Biopharma Introduction
11.2.4 Invetx Revenue in Animal Biopharma Business (2017-2022)
11.2.5 Invetx Recent Developments
11.3 CZ Vaccines
11.3.1 CZ Vaccines Company Details
11.3.2 CZ Vaccines Business Overview
11.3.3 CZ Vaccines Animal Biopharma Introduction
11.3.4 CZ Vaccines Revenue in Animal Biopharma Business (2017-2022)
11.3.5 CZ Vaccines Recent Developments
11.4 Scout Bio
11.4.1 Scout Bio Company Details
11.4.2 Scout Bio Business Overview
11.4.3 Scout Bio Animal Biopharma Introduction
11.4.4 Scout Bio Revenue in Animal Biopharma Business (2017-2022)
11.4.5 Scout Bio Recent Developments
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Animal Biopharma Introduction
11.5.4 Zoetis Revenue in Animal Biopharma Business (2017-2022)
11.5.5 Zoetis Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Animal Biopharma Introduction
11.6.4 Merck Revenue in Animal Biopharma Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Elanco Business Overview
11.7.3 Elanco Animal Biopharma Introduction
11.7.4 Elanco Revenue in Animal Biopharma Business (2017-2022)
11.7.5 Elanco Recent Developments
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Virbac Business Overview
11.8.3 Virbac Animal Biopharma Introduction
11.8.4 Virbac Revenue in Animal Biopharma Business (2017-2022)
11.8.5 Virbac Recent Developments
11.9 Ceva
11.9.1 Ceva Company Details
11.9.2 Ceva Business Overview
11.9.3 Ceva Animal Biopharma Introduction
11.9.4 Ceva Revenue in Animal Biopharma Business (2017-2022)
11.9.5 Ceva Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Company Details
11.10.2 Vetoquinol Business Overview
11.10.3 Vetoquinol Animal Biopharma Introduction
11.10.4 Vetoquinol Revenue in Animal Biopharma Business (2017-2022)
11.10.5 Vetoquinol Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Animal Biopharma Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Vaccine (Bacteria)
Table 3. Key Players of Immune Serum
Table 4. Key Players of Antigen & Antibody
Table 5. Key Players of Others
Table 6. Global Animal Biopharma Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Animal Biopharma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Animal Biopharma Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Animal Biopharma Market Share by Region (2017-2022)
Table 10. Global Animal Biopharma Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Animal Biopharma Market Share by Region (2023-2028)
Table 12. Animal Biopharma Market Trends
Table 13. Animal Biopharma Market Drivers
Table 14. Animal Biopharma Market Challenges
Table 15. Animal Biopharma Market Restraints
Table 16. Global Animal Biopharma Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Animal Biopharma Revenue Share by Players (2017-2022)
Table 18. Global Top Animal Biopharma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2021)
Table 19. Ranking of Global Top Animal Biopharma Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Animal Biopharma Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Animal Biopharma Product Solution and Service
Table 23. Date of Enter into Animal Biopharma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Animal Biopharma Revenue Market Share by Type (2017-2022)
Table 27. Global Animal Biopharma Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Animal Biopharma Revenue Market Share by Type (2023-2028)
Table 29. Global Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Animal Biopharma Revenue Share by Application (2017-2022)
Table 31. Global Animal Biopharma Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Animal Biopharma Revenue Share by Application (2023-2028)
Table 33. North America Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Animal Biopharma Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Animal Biopharma Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Animal Biopharma Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Animal Biopharma Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Animal Biopharma Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Animal Biopharma Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Animal Biopharma Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Animal Biopharma Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Animal Biopharma Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Animal Biopharma Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Animal Biopharma Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Animal Biopharma Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Animal Biopharma Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Animal Biopharma Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Animal Biopharma Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Animal Biopharma Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Animal Biopharma Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Animal Biopharma Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Animal Biopharma Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Animal Biopharma Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Animal Biopharma Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Animal Biopharma Market Size by Country (2023-2028) & (US$ Million)
Table 63. Boehringer Ingelheim Company Details
Table 64. Boehringer Ingelheim Business Overview
Table 65. Boehringer Ingelheim Animal Biopharma Product
Table 66. Boehringer Ingelheim Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 67. Boehringer Ingelheim Recent Developments
Table 68. Invetx Company Details
Table 69. Invetx Business Overview
Table 70. Invetx Animal Biopharma Product
Table 71. Invetx Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 72. Invetx Recent Developments
Table 73. CZ Vaccines Company Details
Table 74. CZ Vaccines Business Overview
Table 75. CZ Vaccines Animal Biopharma Product
Table 76. CZ Vaccines Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 77. CZ Vaccines Recent Developments
Table 78. Scout Bio Company Details
Table 79. Scout Bio Business Overview
Table 80. Scout Bio Animal Biopharma Product
Table 81. Scout Bio Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 82. Scout Bio Recent Developments
Table 83. Zoetis Company Details
Table 84. Zoetis Business Overview
Table 85. Zoetis Animal Biopharma Product
Table 86. Zoetis Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 87. Zoetis Recent Developments
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Animal Biopharma Product
Table 91. Merck Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 92. Merck Recent Developments
Table 93. Elanco Company Details
Table 94. Elanco Business Overview
Table 95. Elanco Animal Biopharma Product
Table 96. Elanco Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 97. Elanco Recent Developments
Table 98. Virbac Company Details
Table 99. Virbac Business Overview
Table 100. Virbac Animal Biopharma Product
Table 101. Virbac Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 102. Virbac Recent Developments
Table 103. Ceva Company Details
Table 104. Ceva Business Overview
Table 105. Ceva Animal Biopharma Product
Table 106. Ceva Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 107. Ceva Recent Developments
Table 108. Vetoquinol Company Details
Table 109. Vetoquinol Business Overview
Table 110. Vetoquinol Animal Biopharma Product
Table 111. Vetoquinol Revenue in Animal Biopharma Business (2017-2022) & (US$ Million)
Table 112. Vetoquinol Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Biopharma Market Share by Type: 2021 VS 2028
Figure 2. Vaccine (Bacteria) Features
Figure 3. Immune Serum Features
Figure 4. Antigen & Antibody Features
Figure 5. Others Features
Figure 6. Global Animal Biopharma Market Share by Application: 2021 VS 2028
Figure 7. Prevention Case Studies
Figure 8. Treatment Case Studies
Figure 9. Animal Biopharma Report Years Considered
Figure 10. Global Animal Biopharma Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Animal Biopharma Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Animal Biopharma Market Share by Region: 2021 VS 2028
Figure 13. Global Animal Biopharma Market Share by Players in 2021
Figure 14. Global Top Animal Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Animal Biopharma Revenue in 2021
Figure 16. North America Animal Biopharma Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 18. North America Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 19. North America Animal Biopharma Market Size Share by Country (2017-2028)
Figure 20. United States Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Animal Biopharma Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 24. Europe Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 25. Europe Animal Biopharma Market Size Share by Country (2017-2028)
Figure 26. Germany Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Animal Biopharma Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Animal Biopharma Market Size Share by Region (2017-2028)
Figure 36. China Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Animal Biopharma Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Animal Biopharma Market Size Share by Country (2017-2028)
Figure 46. Mexico Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Animal Biopharma Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Animal Biopharma Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Animal Biopharma Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Animal Biopharma Market Size Share by Country (2017-2028)
Figure 52. Turkey Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Animal Biopharma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 56. Invetx Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 57. CZ Vaccines Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 58. Scout Bio Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 59. Zoetis Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 61. Elanco Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 62. Virbac Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 63. Ceva Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 64. Vetoquinol Revenue Growth Rate in Animal Biopharma Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の動物用バイオ医薬品市場インサイト及び予測(ワクチン(細菌)、免疫血清、抗原&抗体、その他)(Global Animal Biopharma Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆